August 15, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced that it is the newest MedAxiom Corporate Partner.
August 15, 2007 - InspireMD announced today receipt of orders for its MGuard Coronary stents from key markets in Western ...
August 14, 2007 — ProSolv CardioVascular, a FUJIFILM company, announced today that it is the newest MedAxiom corporate ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its PMA (PreMarket Application) seeking approval of its HeartMate II for bridge-to-transplantation will undergo review by an FDA advisory panel later this year.
August 14, 2007 – GlobalMedTek recently announced a revision of its Version 1.0 for its Medical Software Directory ...
August 14, 2007 - High-speed dual-source computed tomography (DSCT) angiography was 95 percent sensitive and 95 percent ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.
August 14, 2007 - ELA Medical Inc., a Sorin Group company that specializes in the design and manufacture of implantable ...
Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when AngioJet thrombectomy is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of subsequent death, repeat heart attack and stent thrombosis.
August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Mi
Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 8, 2007 - Orbotech Ltd. announced that it has signed a definitive agreement to acquire 3D - Danish Diagnostic ...
August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net ...
August, 8, 2007 - The Medicines Company announced that the new guidelines released yesterday by the American College of ...
August 14, 2007
